About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Tag Archives: #FDA #COVID19 #EUA #BloodPlasma
FDA Credibility on the Line
In normal times, when there is no pandemic threatening our lives and livelihoods, it is essential for FDA to maintain the traditional “gold standard” in relation to the decision-making process for the approval of new treatments. That standard is even … Continue reading
Posted in FDA Image, FDA Policy
Tagged #FDA #COVID19 #EUA #BloodPlasma
Comments Off on FDA Credibility on the Line